MaxCyte, Inc. (MXCT): Revenue
$33.03M
Year ended 2025-12-31
$31.05M
Trailing 12 months to 2026-06-30
-9.3%
3-year compound annual growth
+4.8%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $33.03M | -14.5% | 2026-03-25, From 2025-01-01 |
| 2024-12-31 | $38.63M | -6.4% | 2026-03-25, From 2024-01-01 |
| 2023-12-31 | $41.29M | -6.7% | 2025-03-11, From 2023-01-01 |
| 2022-12-31 | $44.26M | +30.6% | 2024-03-12, From 2022-01-01 |
| 2021-12-31 | $33.89M | +29.5% | 2023-03-15, From 2021-01-01 |
| 2020-12-31 | $26.17M | +21.0% | 2022-03-22, From 2020-01-01 |
| 2019-12-31 | $21.62M | n/a | 2022-03-22, From 2019-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| MaxCyte, Inc. (MXCT) | 2025-12-31 | $33.03M | -14.5% |
| OmniAb, Inc. (OABI) | 2025-12-31 | $18.67M | -29.3% |
| Foxo Technologies Inc. (FOXO) | 2025-12-31 | $16.37M | +304.0% |
| NRC Health (NRC) | 2025-12-31 | $137.39M | -4.0% |
| bioAffinity Technologies, Inc. (BIAF) | 2025-12-31 | $6.16M | -34.2% |
| Absci Corp (ABSI) | 2025-12-31 | $2.80M | -38.2% |
| iSpecimen Inc. (ISPC) | 2025-12-31 | $1.93M | -79.2% |
| OneMedNet Corp (ONMD) | 2025-12-31 | $1.36M | +111.4% |
| Medpace Holdings, Inc. (MEDP) | 2025-12-31 | $2.53B | +20.0% |
Compare MXCT, OABI, FOXO, NRC side by side · Screen every company in Services-Commercial Physical & Biological Research ↗